Board elects new CEO to molecular diagnostics company SIRS-Lab GmbH
Barbara Staehelin: “The SIRS-Lab team is an impressive group, and I believe the SIRS-Lab technology has the potential to unlock this challenging diagnostic field by industry partnerships and with its own product pipeline.”
Nicolas Fulpius and Katrin Uschmann, Board members, comment: “We are very pleased to have recruited Mrs. Staehelin. She has unmatched experience and competences to lead an innovative company like SIRS-Lab to the next level of its development.”
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.